|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"bonnefoi h"
Showing items 1-6 of 6 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-04-26T08:05:28Z |
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer
|
Conte P.;Schneeweiss A.;Loibl S.;Mamounas E.P.;Von Minckwitz G.;Mano M.S.;Untch M.;Chiun-Sheng Huang;Wolmark N.;Rastogi P.;D’Hondt V.;Redondo A.;Stamatovic L.;Bonnefoi H.;Castro-Salguero H.;Fischer H.H.;Wahl T.;Song C.;Boulet T.;Trask P.;Geyer C.E.;Jr.; Conte P.; Schneeweiss A.; Loibl S.; Mamounas E.P.; von Minckwitz G.; Mano M.S.; Untch M.; CHIUN-SHENG HUANG; Wolmark N.; Rastogi P.; D’Hondt V.; Redondo A.; Stamatovic L.; Bonnefoi H.; Castro-Salguero H.; Fischer H.H.; Wahl T.; Song C.; Boulet T.; Trask P.; Geyer C.E.; Jr. |
| 國家衛生研究院 |
2021-02-04 |
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial: 6 years' follow-up
|
Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pieńkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, RD;Viale, G;Thomssen, C; the APHINITY Steering Committee and Investigators |
| 臺大學術典藏 |
2020-03-23T07:18:59Z |
De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|
Smith I.; Toi M.; Tutt A.; Viale G.; Watanabe T.; Whelan T.J.; Xu B.; Galimberti V.; Francis P.; Ejlertsen B.; Denkert C.; Di Leo A.; Cuzick J.; Loibl S.; Colleoni M.; M. Regan M.; Piccart-Gebhart M.; Senn H.-J.; Th?rlimann B.; Andr? F.; Baselga J.; Bergh J.; Bonnefoi H.; Brucker S.Y.; Cardoso F.; Carey L.; Ciruelos E.; Shao Z.; Semiglazov V.; Rutgers E.J.T.; Sedlmayer F.; Ro J.; Pritchard K.; Partridge A.H.; Garber J.; Gulluoglu B.; Goodwin P.; Harbeck N.; F. Hayes D.; CHIUN-SHENG HUANG; Huober J.; Hussein K.; Jassem J.; Jiang Z.; Karlsson P.; Morrow M.; Orecchia R.; Osborne K.C.; Pagani O.; Dubsky P.; Gnant M.; Winer E.P.; Burstein H.J.; Curigliano G.; Curigliano G.;Burstein H.J.;Winer E.P.;Gnant M.;Dubsky P.;Loibl S.;Colleoni M.;M. Regan M.;Piccart-Gebhart M.;Senn H.-J.;Th?Rlimann B.;Andr? F.;Baselga J.;Bergh J.;Bonnefoi H.;Brucker S.Y.;Cardoso F.;Carey L.;Ciruelos E.;Cuzick J.;Denkert C.;Di Leo A.;Ejlertsen B.;Francis P.;Galimberti V.;Garber J.;Gulluoglu B.;Goodwin P.;Harbeck N.;F. Hayes D.;Chiun-Sheng Huang;Huober J.;Hussein K.;Jassem J.;Jiang Z.;Karlsson P.;Morrow M.;Orecchia R.;Osborne K.C.;Pagani O.;Partridge A.H.;Pritchard K.;Ro J.;Rutgers E.J.T.;Sedlmayer F.;Semiglazov V.;Shao Z.;Smith I.;Toi M.;Tutt A.;Viale G.;Watanabe T.;Whelan T.J.;Xu B. |
| 臺大學術典藏 |
2020-03-23T07:18:54Z |
Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))
|
Shao Z.; Semiglazov V.; Rutgers E.J.T.; Sedlmayer F.; Ro J.; Pritchard K.; Partridge A.H.; Pagani O.; Osborne K.C.; Orecchia R.; Morrow M.; Karlsson P.; Jiang Z.; Jassem J.; Curigliano G.;Burstein H.J.;Winer E.P.;Gnant M.;Dubsky P.;Loibl S.;Colleoni M.;Regan M.M.;Piccart-Gebhart M.;Senn H.-J.;Th?Rlimann B.;Andr? F.;Baselga J.;Bergh J.;Bonnefoi H.;Brucker S.Y.;Cardoso F.;Carey L.;Ciruelos E.;Cuzick J.;Denkert C.;Di Leo A.;Ejlertsen B.;Francis P.;Galimberti V.;Garber J.;Gulluoglu B.;Goodwin P.;Harbeck N.;Hayes D.F.;Chiun-Sheng Huang;Huober J.;Khaled H.;Jassem J.;Jiang Z.;Karlsson P.;Morrow M.;Orecchia R.;Osborne K.C.;Pagani O.;Partridge A.H.;Pritchard K.;Ro J.;Rutgers E.J.T.;Sedlmayer F.;Semiglazov V.;Shao Z.;Smith I.;Toi M.;Tutt A.;Viale G.;Watanabe T.;Whelan T.J.;Xu B.; Curigliano G.; Burstein H.J.; Winer E.P.; Gnant M.; Dubsky P.; Loibl S.; Colleoni M.; Regan M.M.; Piccart-Gebhart M.; Senn H.-J.; Th?rlimann B.; Andr? F.; Baselga J.; Bergh J.; Bonnefoi H.; Brucker S.Y.; Cardoso F.; Carey L.; Ciruelos E.; Cuzick J.; Denkert C.; Di Leo A.; Ejlertsen B.; Francis P.; Galimberti V.; Garber J.; Gulluoglu B.; Goodwin P.; Harbeck N.; Hayes D.F.; CHIUN-SHENG HUANG; Huober J.; Khaled H.; Smith I.; Toi M.; Tutt A.; Viale G.; Watanabe T.; Whelan T.J.; Xu B. |
| 國家衛生研究院 |
2020-02 |
Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in pat
|
Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pienkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, R;Viale, G;Thomssen, C |
| 臺大學術典藏 |
2018 |
Reply to 'the St Gallen international expert consensus on the primary therapy of early breast cancer 2017: Te point of view of an international panel of experts in radiation oncology' by Kirova et al.
|
on behalf of the Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017; Xu B.; Whelan T.J.; Bonnefoi H.; Brucker S.Y.; Cardoso F.; Carey L.; Ciruelos E.; Cuzick J.; Denkert C.; Di Leo A.; Ejlertsen B.; Francis P.; Galimberti V.; Garber J.; Gulluoglu B.; Goodwin P.; Harbeck N.; Hayes D.F.; CHIUN-SHENG HUANG; Huober J.; Khaled H.; Jassem J.; Jiang Z.; Karlsson P.; Morrow M.; Orecchia R.; Osborne K.C.; Pagani O.; Partridge A.H.; Pritchard K.; Ro J.; Rutgers E.J.T.; Sedlmayer F.; Semiglazov V.; Shao Z.; Smith I.; Toi M.; Tutt A.; Viale G.; Watanabe T.; Bergh J.; Baselga J.; Thrlimann B.; Andr? F.; Senn H.-J.; Piccart-Gebhart M.; Regan M.M.; Colleoni M.; Loibl S.; Gnant M.; Winer E.P.; Burstein H.J.; Curigliano G.; Dubsky P.; Dubsky P.;Curigliano G.;Burstein H.J.;Winer E.P.;Gnant M.;Loibl S.;Colleoni M.;Regan M.M.;Piccart-Gebhart M.;Senn H.-J.;Thrlimann B.;Andr? F.;Baselga J.;Bergh J.;Bonnefoi H.;Brucker S.Y.;Cardoso F.;Carey L.;Ciruelos E.;Cuzick J.;Denkert C.;Di Leo A.;Ejlertsen B.;Francis P.;Galimberti V.;Garber J.;Gulluoglu B.;Goodwin P.;Harbeck N.;Hayes D.F.;Chiun-Sheng Huang;Huober J.;Khaled H.;Jassem J.;Jiang Z.;Karlsson P.;Morrow M.;Orecchia R.;Osborne K.C.;Pagani O.;Partridge A.H.;Pritchard K.;Ro J.;Rutgers E.J.T.;Sedlmayer F.;Semiglazov V.;Shao Z.;Smith I.;Toi M.;Tutt A.;Viale G.;Watanabe T.;Whelan T.J.;Xu B.;On Behalf Of The Panel Members Of The St Gallen International Expert Consensus On The Primary Therapy Of Early Breast Cancer 2017 |
Showing items 1-6 of 6 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
